Recombinant luteinizing hormone
Term · Oncology and biomedicine · MLC-T-ONC-016444
Any recombinant form of the endogenously produced heterodimer glycoprotein luteinizing hormone (LH) normally made by the anterior pituitary gland, that can be used for the treatment of LH deficiency. Upon administration, recombinant LH mimics the biological activity of endogenous LH. In females, this triggers ovulation and the development of the corpus luteum. In males, LH stimulates Leydig cells to produce testosterone.
| Identifier | MLC-T-ONC-016444 |
|---|---|
| Field | Oncology and biomedicine |
| Abbreviation | therapeutic LH |
| Synonyms | interstitial cell-stimulating hormone; leuteinizing hormone; lutropin; luteinizing hormone; Recombinant LH |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-016444",
"term": "Recombinant luteinizing hormone",
"field": "Oncology and biomedicine",
"definition": "Any recombinant form of the endogenously produced heterodimer glycoprotein luteinizing hormone (LH) normally made by the anterior pituitary gland, that can be used for the treatment of LH deficiency. Upon administration, recombinant LH mimics the biological activity of endogenous LH. In females, this triggers ovulation and the development of the corpus luteum. In males, LH stimulates Leydig cells to produce testosterone.",
"abbreviation": "therapeutic LH",
"synonyms": [
"interstitial cell-stimulating hormone",
"leuteinizing hormone",
"lutropin",
"luteinizing hormone",
"Recombinant LH"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/recombinant-luteinizing-hormone/"
}
Record 14,190 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.